Big Pharma holt sich blaues Auge
نویسندگان
چکیده
Covid beschert den großen Pharmaunternehmen stagnierende Umsätze und Erträge. Österreichs spielen im Konzert der Großen eine kleine, aber vernehmbare Rolle.
منابع مشابه
Big Pharma (The Play)
A nyone who has experienced the assault of the pharmaceutical industry's marketing campaigns would appreciate Jennifer Berry's one-person play Big Pharma: The Rise of the Anti-Depressant Drug Industry and the Loss of a Generation. Since the mid-1990s, spending on drug promotion has grown steadily, reaching $21 billion in 2002. Berry explores the fallout of this expanded marketing blitz through ...
متن کاملBypassing big pharma.
There have been many resounding victories in the war against coronary artery disease. Among those are antiarrhythmic drugs, pacemakers, coronary bypass surgery, coronary angioplasty, reperfusion therapy, and statins. But the one goal that has continuously eluded us has been the clinical availability of an effective cardioprotective agent. Although reperfusion therapy has partially achieved the ...
متن کاملThe influence of big pharma.
Areport published last week on “the influence of the pharmaceutical industry” describes a strong United Kingdom pharmaceutical industry, whose net exports are worth over £3bn ($5.6bn; €4.3bn) annually. The industry’s declared goal is “to bring patients life-enhancing medicines,” a goal “not only necessary but noble.” The House of Commons health committee examined the means used to achieve this ...
متن کاملChanging Strategies of Big Pharma
The life sciences are transforming pharmaceutical companies in terms of both internal R&D processes and strategies for external knowledge capture mergers, acquisitions, strategic alliances and licensing. Dr. Mittra’s research on life science innovation and the pharmaceutical industry reveals that these are a cluster of related activities that provide various strategic options for managing innov...
متن کاملRebuilding Big Pharma ’ s Business Model
Four inter-related building blocks can provide the new foundation: focusing R&D efforts and commercial capabilities; making use of product and capability partnerships; providing customer solutions (not just “therapeutics”), and creating a business unit based organization model instead of a functional one. Companies need to find a combination of these building blocks that makes best use of their...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Das Österreichische Gesundheitswesen Ökz
سال: 2021
ISSN: ['2730-7271', '0472-5530']
DOI: https://doi.org/10.1007/s43830-021-0054-2